OXYPHENBUTAZONE (“TANDERIL”) IN RHEUMATIC DISEASE
- 1 July 1962
- journal article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 2 (2) , 49-51
- https://doi.org/10.5694/j.1326-5377.1962.tb19970.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- OXYPHENBUTAZONE (“TANDERIL”, G 27202): AN ANTIRHEUMATIC DERIVATIVE OF PHENYLBUTAZONEThe Medical Journal of Australia, 1961
- BIOCHEMICAL PHARMACOLOGICAL CONSIDERATIONS OF PHENYLBUTAZONE AND ITS ANALOGUESAnnals of the New York Academy of Sciences, 1960
- THE PHARMACOLOGY OF PHENYLBUTAZONE ANALOGUESAnnals of the New York Academy of Sciences, 1960
- Controlled Trial of G27 202 (p-Hydroxyphenylbutazone) in Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1959
- The clinical evaluation of a new anti-inflammatory agent: A preliminary reportThe American Journal of Surgery, 1959
- The comparative effects of phenylbutazone and G27202 (metabolite i) in patients with rheumatoid arthritis: An assessment of methods for antirheumatic drug evaluationArthritis & Rheumatism, 1959
- Phenylbutazone and Its DerivativesBMJ, 1959